Jeroen Schouten - Concepedia

Author

Jeroen Schouten

Also Known As

Diamantis P. Kofteridis, G Ultee, Goran Zangana, J A Schouten, J Schouten, J. A Schouten, J. A. Schouten, J. SCHOUTEN, J. Schouten, J.A. Schouten

190

Publications

9.4K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center Canisius-Wilhelmina Ziekenhuis University Medical Center Utrecht Erasmus MC

About

Jeroen Schouten is an author at Radboud University Nijmegen specializing in medicine, antimicrobial resistance, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	2.1K
2	Public Health	6	6	414
3	Critical Care Medicine	4	4	1K
4	Emergency Medicine	4	4	944
5	Nursing	1	1	10

Jeroen Schouten

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial Evelien de Jong, Jos A van Oers, Albertus Beishuizen, The Lancet Infectious Diseases Antibiotic TreatmentOpen-label TrialCritical Care MedicineAntimicrobial StewardshipAntibiotics	2016	789
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion Paul E. Verweij, Bart Rijnders, Roger J. M. Brüggemann, Intensive Care Medicine	2020	426
COVID-19: don't neglect antimicrobial stewardship principles! Benedikt Huttner, Gaud Catho, José Ramón Paño‐Pardo, Clinical Microbiology and Infection Antimicrobial Stewardship PrinciplesGlobal Health CrisisCovid-19 PandemicInfection ControlMedicine	2020	389
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project Matteo Bassetti, Daniele Roberto Giacobbe, Antonio Vena, Critical Care	2019	227
Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline Elske Sieswerda, Mark de Boer, Marc J. M. Bonten, Clinical Microbiology and Infection	2020	204
Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial Peter Pickkers, Suzanne Heemskerk, Jeroen Schouten, Critical Care	2012	194
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP) Alexis Tabah, Matteo Bassetti, Marin H. Kollef, Intensive Care Medicine Critical Care ManagementIntensive Care MedicineCritical Care MedicineAntibioticsAntimicrobial Stewardship	2019	169
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis Paul E. Verweij, Roger J. M. Brüggemann, Élie Azoulay, Intensive Care Medicine	2021	155
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19 Simin Florescu, Delia Stanciu, Mihaela Zaharia, JAMA	2022	147
Clinical indicators: development and applications. Hub Wollersheim, Rosella Hermens, Marlies Hulscher, PubMed	2007	138

Page 1